International Stem Cell (ISCO) Current Deferred Revenue (2010 - 2013)
International Stem Cell (ISCO) posted quarterly Current Deferred Revenue of $3000.0 for Q4 2013, down 98.71% year-over-year from $233000.0 in Q4 2012, and down 98.08% quarter-over-quarter from $156000.0 in Q3 2013.
International Stem Cell (ISCO) Current Deferred Revenue (2010 - 2013) Analysis & Trends
International Stem Cell (ISCO) has reported Current Deferred Revenue for 4 consecutive years, with $3000.0 the latest figure, recorded in Q4 2013.
- In Q4 2013, Current Deferred Revenue fell 98.71% year-over-year to $3000.0; the TTM figure through Dec 2013 stood at $3000.0 (down 98.71% YoY), while the FY2013 annual figure was $3000.0, down 98.71% from the prior year.
- Current Deferred Revenue eased to $3000.0 in Q4 2013 per ISCO's latest filing, from $156000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $760000.0 in Q4 2010 and bottomed at $3000.0 in Q4 2013.
- Historically, Current Deferred Revenue has averaged $216682.8 across 4 years, with a median of $172000.0 in 2013.
- Annual changes were most pronounced in 2012 — Current Deferred Revenue grew 23.28% — and 2013, when it plunged 98.71%.
- International Stem Cell's Current Deferred Revenue stood at $760000.0 in 2010, then plunged by 75.13% to $189000.0 in 2011, then advanced by 23.28% to $233000.0 in 2012, then slumped by 98.71% to $3000.0 in 2013.
- Business Quant data shows ISCO's Current Deferred Revenue at $3000.0 in Q4 2013, $156000.0 in Q3 2013, and $172000.0 in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | International Stem Cell | 4.32 Mn | 3.23 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 3,000.00 |
| Sep 30, 2013 | 156,000.00 |
| Jun 30, 2013 | 172,000.00 |
| Dec 31, 2012 | 233,000.00 |
| Mar 31, 2012 | 112,000.00 |
| Dec 31, 2011 | 189,000.00 |
| Sep 30, 2011 | 187,311.00 |
| Jun 30, 2011 | 137,834.00 |
| Dec 31, 2010 | 760,000.00 |